FDA’s Fiscal 2025 Budget Stalled Until Congress Reconvenes

August 6, 2024
Drugs Devices Regulatory Affairs Regulatory Affairs
With the House and Senate now in recess until Sept. 9, the FDA is once again facing into a new fiscal year unsure of its funding from Congress.

To View This Article:

Login

Subscribe To FDAnews

Buy This Article Now

Add this article to your cart for $25.00

Upcoming Events

Featured Products

Featured Stories

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More